Eurofarma Innovation and Growth Strategy
11
GEOGRAPHIC
CAPILLARITY
Increase in Results
#22
#34
1.2%
#105
0.6%
0.1%
2016
2021
2026e
Colombia
12.3%
International Operations
Net Revenue
(R$ million)
Ecuador
2.2%
EBITDA and Margin²
(R$ million)
#30
#14
1.7%
#12
2.8%
Peru
1.0%
16%
16%
9.6%
L
2016
2021
2026e
15%
#28
#18
4%
#12
2.4%
Bolivia
0.8%
1.0%
+21%
2016
2021
2026e
1.9%
Paraguay
+394%
634
523
1H21
1H22
% Consolidated Net Revenue
0.5%
Pharma Total Market¹
Chile
101
US$ bi (Retail + Non-retail)
13.6%
#11
#18
20
1H21
44%
56%
54.3
2.2%
1.6%
1H22
#62
0.3%
EBITDA Margin
Brazil
LatAm (ex-Brazil)
2016
2021
2026e
1- IQVIA, excluding Covid-19 vaccines / 2- Adjusted and management data
#30
#38
0.8%
1.3% eurofarma
2026e
Mexico
22.7%
2021
Central America
and Caribbean
#10
23.5%
#40
0.6%
#17
1.4%
2.3%
2016
2021
2026e
Market Share and Ranking
#7
#10
2.9%
#12
2.6%
3.8%
Uruguay
5.9%
% % International sales operations (1H22)
✓ Production Facilities
Argentina
7.8%
2016
2021
2026eView entire presentation